How Much Does Semaglutide Cost Without Insurance in 2026?

If you searched this question two years ago, the honest answer was grim: more than $1,000 a month, with no realistic way around it. That has changed. In 2026 the brand-name cash price for semaglutide runs between $149 and $499 a month (verified 2026-09-14 against Novo Nordisk’s own price guides), depending on which product you are prescribed and what dose you are on. That is a range across products and doses, not a single price.

The catch is that there is no single “semaglutide price.” Semaglutide is sold in the United States under three brand names with different prices, and the pill costs less than the shot at most doses. This guide lays out the actual published numbers, where they come from, and what to watch for.

A note before we start: nothing here is medical advice. Which semaglutide product is right for you, and whether any of them is appropriate at all, is a conversation for you and a healthcare provider.

What is the list price of Ozempic and Wegovy right now?

The list price, also called the wholesale acquisition cost or WAC, is what the manufacturer sets before any rebates or discounts. It is the number that shows up in headlines.

• Ozempic: $1,027.51 for a one-month pen [1]
• Wegovy (pen, HD pen, or 30-tablet bottle): $1,349.02 per package [2]

For comparison, CMS recorded a $959 list price per 30-day supply for the combined Ozempic, Rybelsus and Wegovy group in calendar year 2024, using actual prescription fills [3].

Almost nobody pays list price at the counter. But it is not fiction either. If you have a high-deductible health plan and have not met your deductible, or your plan uses coinsurance (a percentage rather than a flat copay), your bill is calculated from a number close to that. That is exactly why Novo Nordisk announced on February 24, 2026 that it will cut the list price of Wegovy, Ozempic and Rybelsus to $675 a month effective January 1, 2027, roughly a 50% cut for Wegovy and 35% for Ozempic [4].

How much is Wegovy per month without insurance?

Novo Nordisk publishes a self-pay price list for its own direct pharmacy, NovoCare Pharmacy, and honors the same prices at more than 70,000 retail pharmacies and through TrumpRx.gov [5][6].

Wegovy pen (injection):

Dose	New-patient price	Standard price
0.25 mg	$199/month (first 2 fills)	$349/month
0.5 mg	$199/month (first 2 fills)	$349/month
1 mg	—	$349/month
1.7 mg	—	$349/month
2.4 mg	—	$349/month
Wegovy HD 7.2 mg	—	$399/month

One month means one box of four pens. The $199 introductory price applies to patients new to the Wegovy savings offer or NovoCare Pharmacy, covers two monthly fills, and runs through December 31, 2026 [5][7].

Wegovy pill (tablets):

Dose	Self-pay price
1.5 mg	$149/month
4 mg	$199/month
9 mg	$299/month
25 mg	$299/month

One month is one bottle of 30 tablets [5]. The 25 mg tablet is the dose approved for chronic weight management.

How much is Ozempic per month without insurance?

Ozempic is the type 2 diabetes brand of semaglutide. Its self-pay tiers are similar but not identical to Wegovy’s [8]:

Ozempic pen:

Dose	New-patient price	Standard price
0.25 mg	$199/month (first 2 fills)	$349/month
0.5 mg	$199/month (first 2 fills)	$349/month
1 mg	—	$349/month
2 mg	—	$499/month

Ozempic pill (formerly Rybelsus): $149/month for 1.5 mg, $199/month for 4 mg, $299/month for 9 mg.

The 2 mg pen is the one exception to the flat pricing. It stays at $499 a month, which Novo Nordisk noted explicitly when it cut the standard self-pay price in November 2025 [7].

One naming change to know about: in 2026 Novo Nordisk retired the Rybelsus brand in the United States and now sells the next-generation oral semaglutide tablets for type 2 diabetes as Ozempic tablets. The dose numbers changed too, because the reformulated tablets deliver more semaglutide per milligram. Talk to your pharmacist if your bottle looks different than it used to.

Why did the price drop so much since 2024?

Three things happened at once.

Compounded semaglutide created real price pressure. While semaglutide was on the FDA drug shortage list, compounding pharmacies could legally make copies, and telehealth companies sold them for a few hundred dollars a month. That ended when the FDA declared the shortage resolved on February 21, 2025, but by then consumers had learned that a few hundred dollars a month was possible [9].

Novo Nordisk built a direct channel. NovoCare Pharmacy launched on March 5, 2025 at $499 a month for any Wegovy dose, down from about $650. On November 17, 2025 the standard price dropped again to $349, with a $199 starter offer added [7].

The federal government got involved. On November 6, 2025 the White House announced most-favored-nation pricing agreements with Novo Nordisk and Eli Lilly, and on February 5, 2026 launched TrumpRx.gov, a federal coupon site that displays the same manufacturer self-pay prices [1].

Is there a cheaper way if I plan to stay on it a while?

Yes. On March 31, 2026 Novo Nordisk launched a multi-month subscription for self-pay patients. It went live through Ro, WeightWatchers and LifeMD, with Hims & Hers, Sesame and other telehealth partners named as joining after launch [10]:

• 3-month plan: $329/month for the Wegovy pen
• 6-month plan: $299/month
• 12-month plan: $249/month

The 9 mg and 25 mg Wegovy pills run $289, $269 and $249 on the same terms. Novo Nordisk says the deepest plan saves up to $1,200 a year on the pen versus the $349 standard price, and up to $600 a year on the pill versus $299 [10].

Read these as prepaid commitment prices rather than monthly bills. The lower per-month figure comes from buying the whole term at once, so the 12-month plan asks for the full year up front, and Wegovy HD 7.2 mg was not in the program at launch. Enrollment runs through the telehealth partners rather than NovoCare Pharmacy, whose own pages do not show subscription tiers, and any platform membership fee sits on top of the medicine price [10].

The trade-off is commitment. You are locking in a longer term, and telehealth platforms typically charge their own membership or program fee on top of the medication price. Ask what the all-in monthly number is before you sign up.

What if I have insurance but it does not cover weight-loss drugs?

You have two paths and you cannot combine them.

If your plan covers the drug, the manufacturer savings card can bring your copay to as little as $25 a month, with a maximum of $100 in help per one-month fill [2][8]. That is the cheapest route available to most insured people.

If your plan does not cover it, you pay the self-pay price above. The savings card will not help you, because it requires coverage. One important detail: when you buy outside your insurance using a self-pay offer, that money does not count toward your deductible or out-of-pocket maximum, and you agree not to submit it to your insurer for reimbursement [2][6].

Are these prices going to stay this low?

Nothing here is permanent. Every one of these programs carries language saying the manufacturer can modify or cancel it at any time, and several have hard end dates. The $199 introductory pen price is written to run through December 31, 2026. The temporary $149 price on the 4 mg Wegovy pill ended August 31, 2026, moving that dose to $199.

The more durable change is the list price cut to $675 scheduled for January 1, 2027 [4]. That one matters most for people with coinsurance or an unmet deductible, because their bill is a function of list price. It does not change the cash prices described here; Novo Nordisk said explicitly that the self-pay channel is unaffected [4].

What should I actually do?

A practical order of operations:

1. Check whether your plan covers it at all. Pull your Summary of Benefits and Coverage, or use the manufacturer’s coverage-check tool. If it is covered, ask about the savings card.
2. If it is not covered, compare the self-pay routes. NovoCare Pharmacy, a retail pharmacy with the manufacturer offer, GoodRx and TrumpRx.gov all currently land on the same Novo Nordisk numbers. Pick on convenience.
3. Ask your prescriber whether an oral option is on the table. At $149 to $299 a month, the pill is the least expensive branded semaglutide. Whether it fits your situation is a clinical question, and the pill has strict timing rules that the shot does not.
4. If you are on Medicare, stop and read the Medicare rules separately. None of these self-pay offers are available to people with Medicare, Medicaid, TRICARE or VA coverage.

Sources

1. Ozempic Pen on TrumpRx — TrumpRx.gov, retrieved 2026-09-14
2. Wegovy Cost, Coverage, and Savings Resources — NovoCare, retrieved 2026-09-14
3. Negotiated Prices for Initial Price Applicability Year 2027 — CMS, 2025-11-25
4. Novo Nordisk announces significant reduction in US list price — Novo Nordisk, 2026-02-24
5. Wegovy price guide — Novo Nordisk, retrieved 2026-09-14
6. NovoCare Pharmacy — Novo Nordisk, retrieved 2026-09-14
7. Novo Nordisk launches introductory self-pay offer for $199 per month — Novo Nordisk, 2025-11-17
8. Ozempic pill and pen price guide — Novo Nordisk, 2026-05
9. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize — FDA, 2026-04-01
10. Novo Nordisk launches multi-month subscription program for Wegovy — Novo Nordisk, 2026-03-31
11. Wegovy HD available now nationwide — Novo Nordisk, 2026-04-07